Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
09/2003
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003US20030176492 Having antimalarial activity against the proliferation of malarial parasites and is therefore useful as an antimalarial drug
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176366 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2423259A1 New compounds derived from quinazoline, the process for preparing them, and the pharmaceutical compositions containing them
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1021426B1 Catalytic asymmetric epoxidation
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/16/2003US6620947 Such as ((2R(1E,3R),3S(4Z),4R))-7-(Tetrahydro-2-(4-(3-chlorophenoxy)-3-hydroxy-1 -butenyl)-4-hydroxy-3-furanyl)-4-heptenoic acid
09/12/2003WO2003074508A1 Compounds and methods of treating cell proliferative diseases
09/12/2003WO2003073870A1 Health foods having antiallergic effect
09/12/2003CA2477003A1 Compounds and methods of treating cell proliferative diseases
09/11/2003US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/11/2003US20030170725 Modulation of polyketide synthase gene modules; anticancer agents, fungicide, bactericide
09/11/2003US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1137644B1 Benzofuran derivatives, their preparation and use
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/09/2003CA2248953C Novel benzofuranone derivatives and process for producing the same
09/04/2003WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
09/04/2003WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
09/04/2003WO2003072197A1 Acc inhibitors
09/04/2003US20030166710 A cylic peroxide containing methyl carboxylic acid or ester; anticarcinogenic agent
09/04/2003US20030166684 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1339703A1 A process for the preparation of paclitaxel
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003CN1440404A Benzofuran derivatives and their use as antibacterial agents
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070726A1 Pyranones useful as atm inhibitors
08/28/2003WO2003070719A1 Bryostatin analogues, synthetic methods and uses
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003US20030162661 Selective control of harmful plants in crops of useful plants
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/26/2003US6610860 C7 ester substituted taxanes
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/21/2003WO2003068769A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003US20030158424 Substituted alpha, beta-anellated butyrolactones
08/21/2003US20030158175 Chroman derivatives as 5-hydroxytrytamine-6 ligands
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1335908A2 Peroxisome proliferator activated receptor alpha agonists
08/20/2003CN1436781A Synthesis of 2,2',3,3'-benzophenone tetracidic dianhydride
08/20/2003CN1436780A Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative
08/20/2003CN1118476C Antiviral protease inhibitors
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608004 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/14/2003WO2003067259A1 E2 displacement assay for identifying inhibitors of hpv
08/14/2003WO2003065975A2 Processes for preparing crystalline and amorphous mupirocin calcium
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/13/2003EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH)
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1075470B1 Novel analgesic and immunomodulatory cannabinoids
08/13/2003CN1117741C Heterocyclic fungicides
08/12/2003US6605707 Process for the preparation of 6-O-propargyl erythromycin derivatives
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/07/2003WO2003028662A3 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
08/07/2003WO2003011873A8 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
08/07/2003US20030149294 Process for the preparation of latanoprost
08/07/2003US20030149193 Powder coating; to producing coatings having a high crosslinking density and a high level of stability towards weathering and ultraviolet radiation
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/05/2003US6602898 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
07/2003
07/31/2003WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144334 Cyclopentabenzofuran derivatives and their use
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/30/2003EP1144406B1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
07/30/2003EP0902022B1 Novel benzofuranone derivatives and process for producing the same
07/30/2003CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
07/29/2003US6600062 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/29/2003US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059874A2 Aromatic thioether liver x-receptor modulators
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 120